P.J. Bostrom | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where P.J. Bostrom is active.

Explore More

Publication

Featured researches published by P.J. Bostrom.

BJUI | 2011

Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort

Greg Trottier; Monique J. Roobol; Nathan Lawrentschuk; P.J. Bostrom; Kimberly A. Fernandes; Antonio Finelli; Karen Chadwick; Andrew Evans; Theodorus H. van der Kwast; Ants Toi; Alexandre Zlotta; Neil Fleshner

Study Type – Prognosis (inception cohort)

BJUI | 2012

Does patient age affect survival after radical cystectomy

David Horovitz; Polat Turker; P.J. Bostrom; Tuomas Mirtti; Martti Nurmi; Cynthia Kuk; Girish Kulkarni; Neil Fleshner; Antonio Finelli; Michael A.S. Jewett; Alexandre Zlotta

Study Type – Therapy (cohort)

European Urology Supplements | 2014

793 A multidisciplinary bladder cancer clinic delivers personalized care for complex bladder cancer patients

Thomas Hermanns; Yanliang Wei; B. Bindi; Raj Satkunasivam; Paul Athanasopoulos; P.J. Bostrom; C. Kuk; Arnoud J. Templeton; S. S. Sridhar; T.H. van der Kwast; Peter Chung; Robert G. Bristow; M. Milosevic; Neil Fleshner; M.A.S. Jewett; A.R. Zlotta; Girish Kulkarni

European Urology Supplements | 2011

765 THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER

B. Van Rhijn; P.J. Bostrom; S.F. Shariat; A. Finelli; Arthur I. Sagalowsky; Neil Fleshner; B. Bapat; Hannes Kortekangas; Raheela Ashfaq; Tuomas Mirtti; M.A.S. Jewett; Yair Lotan; Th. H. van der Kwast; A.R. Zlotta

European Urology Supplements | 2017

A propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic

Girish Kulkarni; Thomas Hermanns; Yanliang Wei; Bimal Bhindi; Raj Satkunasivam; Paul Athanasopoulos; P.J. Bostrom; C. Kuk; Kathy Li; Arnoud J. Templeton; S. S. Sridhar; T.H. van der Kwast; Peter Chung; Robert E. Bristow; M. Milosevic; Padraig Warde; Neil Fleshner; M.A.S. Jewett; Shaheena Bashir; A.R. Zlotta

European Urology Supplements | 2014

412 Pathological validation of adjuvant anti-fibroblast growth factor receptor 3 (FGFR3) treatment for bladder cancer

Yann Neuzillet; Laura S. Mertens; S.F. Shariat; P.J. Bostrom; Tuomas Mirtti; Arthur I. Sagalowsky; Raheela Ashfaq; Annegien Broeks; S. Horenblas; Carolyn D. Hurst; Darren C. Tomlinson; Margaret A. Knowles; B. Bapat; M.A.S. Jewett; A.R. Zlotta; Joyce Sanders; Yair Lotan; T.H. van der Kwast; B. Van Rhijn

European Urology Supplements | 2012

905 Hypoxia is independently associated with poor outcome in urothelial bladder cancer patients treated with radical cystectomy

P.J. Bostrom; John Thoms; B. Van Rhijn; Omer Ahmed; O. Stakhovskyi; David Margel; Andrew Evans; Tuomas Mirtti; Jenna Sykes; M. Pintilie; Matti Laato; Michael Milosevic; A.R. Zlotta; Robert G. Bristow

European Urology Supplements | 2012

554 Upstaging of urothelial cancer at the time of radical cystectomy – associated factors and effect on outcome

Polat Türker; P.J. Bostrom; M. Wraclowski; Rhijn B.W.G. Van; Hannes Kortekangas; C. Kuk; Neil Fleshner; M.A.S. Jewett; A. Finelli; T.H. Van Der Kwast; Andrew Evans; Joan Sweet; M. Latu; A.R. Zlotta

European Urology Supplements | 2010

690 NERVE-SPARING RADICAL PROSTATECTOMY IN SELECTED HIGH-RISK AND LOCALLY ADVANCED PROSTATE CANCERS IS ASSOCIATED WITH LOW POSITIVE MARGIN RATES USING A COMBINATION OF PREOPERATIVE MRI, SPECIAL INSTRUMENTATION AND INTRA-OPERATIVE FROZEN SECTIONS

A.R. Zlotta; Greg Trottier; B. Van Rhijn; P.J. Bostrom; Sultan Alkhateeb; S. Hanna; Andrew Evans; Neil Fleshner; Nathan Lawrentschuk; T.H. Van Der Kwast

European Urology Supplements | 2010